Edible Oil · Founded 1988 · www.marico.com · BSE 531642 · NSE MARICOLTD · ISIN INE196A01026
No Notes Added Yet
Business
Marico Ltd. is a leading Indian consumer goods company operating in the health, beauty, and wellness space. Its core business involves developing, manufacturing, and marketing products across various categories, including edible oils, coconut oils, value-added hair oils, foods, male grooming, and premium personal care. The company makes money by selling these products through an extensive distribution network across India and several international markets. While strong in edible oils with brands like Saffola, its portfolio extends significantly into other consumer staples and discretionary categories.
Revenue Mix
Marico primarily segments its business into India and International operations.
India Business: This is the largest contributor to revenue and includes:
Edible Oils & Foods: Saffola (super premium refined edible oils, oats, honey, peanut butter, etc.).
Coconut Oils: Parachute (pure coconut oil).
Value-Added Hair Oils (VAHO): Parachute Advanced, Nihar Naturals, Bajaj Almond Drops (post acquisition).
Premium Personal Care: Livon (hair care), Set Wet (male grooming), Beardo (male grooming).
International Business: Contributes a significant portion of revenue and spans markets in Asia (Bangladesh), MENA, South Africa, and Southeast Asia, with a focus on core categories like hair oils, coconut oil, and personal care.
(Specific revenue percentages for each sub-category are not readily disclosed in a consolidated manner, but India business typically accounts for ~75-80% of total revenue).
Industry
Marico operates in the highly competitive Fast-Moving Consumer Goods (FMCG) industry, specifically within the edible oil, hair care, and broader personal care and foods segments. The Indian FMCG market is characterized by a vast consumer base, diverse preferences, and significant potential, particularly in rural areas. Marico holds strong leadership positions in several categories, including:
Market leader in the coconut oil segment with Parachute.
Leader in the super premium refined edible oil category with Saffola.
Significant player in the value-added hair oils and male grooming segments.
It competes with both large multinational corporations (e.g., Hindustan Unilever, Procter & Gamble) and strong domestic players (e.g., Dabur, Godrej Consumer Products), as well as regional and unorganized players.
MOAT
Marico possesses several durable competitive advantages:
Strong Brand Equity: Iconic brands like Parachute and Saffola are household names, commanding high consumer trust and loyalty built over decades. This allows for premium pricing and easier market entry for new products under these brands.
Extensive Distribution Network: A robust and deep distribution reach across urban and rural India, ensuring product availability even in remote areas. This is a significant barrier to entry for new players.
Market Leadership & Scale: Dominant positions in key categories provide economies of scale in manufacturing, procurement, and advertising, leading to cost efficiencies.
Innovation & Adaptation: Demonstrated ability to innovate and extend core brands into adjacent categories (e.g., Saffola's expansion into oats, honey, and other healthy foods) and adapt to evolving consumer preferences.
Growth Drivers
Premiumization Trend: Consumers' increasing willingness to pay for value-added, healthier, and specialized products (e.g., Saffola's gourmet range, premium male grooming products).
Rural Market Penetration: Untapped potential in rural and semi-urban areas of India, driven by rising disposable incomes and improved infrastructure.
Expansion into Adjacent Categories: Further diversification within the health and wellness foods segment and premium personal care.
International Business Growth: Leveraging existing market presence and expanding into new geographies, particularly in emerging markets.
Digital & E-commerce Channels: Increasing penetration and sales through online platforms and direct-to-consumer models.
Health & Wellness Focus: Capitalizing on the growing consumer emphasis on healthy lifestyles, which aligns with brands like Saffola.
Risks
Commodity Price Volatility: Key raw materials like copra (for coconut oil) and edible oils are subject to significant price fluctuations, impacting gross margins.
Intense Competition: Aggressive competition from large FMCG players and smaller regional brands can lead to pricing pressures and market share erosion.
Changes in Consumer Preferences: Rapid shifts in trends or tastes can render existing products less appealing, requiring continuous innovation.
Economic Slowdown/Inflation: A downturn in economic activity or persistent high inflation can reduce consumer purchasing power, particularly for discretionary personal care and premium food items.
Regulatory Changes: Adverse changes in food safety, advertising, packaging, or environmental regulations could impact operations and costs.
Supply Chain Disruptions: Geopolitical events or natural disasters can disrupt the global supply chain, affecting production and distribution.
Management & Ownership
Marico is promoted by the Mariwala family, with Mr. Harsh Mariwala serving as the Chairman. The promoter group holds a significant stake in the company, indicating strong alignment of interests. Management is generally regarded as professional, experienced, and forward-looking, with a track record of strategic brand building, market leadership, and successful diversification. The company has a well-defined corporate governance structure, and the management team has consistently focused on sustainable growth and innovation.
Outlook
Marico's outlook is characterized by a balanced set of opportunities and challenges. The company is well-positioned to benefit from India's long-term consumption growth story, driven by its strong brand portfolio, extensive distribution, and focus on health and wellness. Continued premiumization, rural market penetration, and diversification into adjacent food categories offer significant growth avenues. Furthermore, its established international business provides a cushion against potential slowdowns in any single market.
However, the company faces inherent risks from volatile raw material prices, intense competition, and potential shifts in consumer preferences. Sustained high inflation could curb discretionary spending, impacting growth in its value-added categories. The ability to innovate consistently, manage costs effectively, and maintain distribution superiority will be crucial for Marico to navigate these challenges and sustain its growth trajectory in the dynamic FMCG landscape.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 2422 | 2278 | 2643 | 2664 | 2794 | 2730 | 3259 | 3482 | 3537 | 3333 |
| Other Income | 43 | 15 | 37 | 82 | 42 | 47 | 56 | 49 | 39 | 60 |
| Total Income | 2465 | 2293 | 2680 | 2746 | 2836 | 2777 | 3315 | 3531 | 3576 | 3393 |
| Total Expenditure | 1909 | 1836 | 2017 | 2142 | 2261 | 2272 | 2604 | 2922 | 2945 | 2812 |
| Operating Profit | 556 | 457 | 663 | 604 | 575 | 505 | 711 | 609 | 631 | 581 |
| Interest | 19 | 17 | 17 | 11 | 13 | 12 | 10 | 12 | 14 | 17 |
| Depreciation | 42 | 41 | 41 | 41 | 44 | 52 | 45 | 47 | 50 | 60 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 495 | 399 | 605 | 552 | 518 | 441 | 656 | 550 | 567 | 504 |
| Provision for Tax | 109 | 79 | 131 | 119 | 112 | 96 | 143 | 118 | 107 | 96 |
| Profit After Tax | 386 | 320 | 474 | 433 | 406 | 345 | 513 | 432 | 460 | 408 |
| Adjustments | -3 | -2 | -10 | -10 | -7 | -2 | -9 | -12 | -13 | -17 |
| Profit After Adjustments | 383 | 318 | 464 | 423 | 399 | 343 | 504 | 420 | 447 | 391 |
| Adjusted Earnings Per Share | 3 | 2.5 | 3.6 | 3.3 | 3.1 | 2.7 | 3.9 | 3.2 | 3.4 | 3 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 5733 | 6017 | 5918 | 6322 | 7334 | 7315 | 8048 | 9512 | 9764 | 9653 | 10831 | 13611 |
| Other Income | 59 | 94 | 97 | 85 | 103 | 127 | 97 | 101 | 144 | 175 | 208 | 204 |
| Total Income | 5792 | 6111 | 6015 | 6407 | 7437 | 7442 | 8145 | 9613 | 9908 | 9828 | 11039 | 13815 |
| Total Expenditure | 4863 | 4966 | 4759 | 5186 | 6008 | 5849 | 6460 | 7834 | 7954 | 7660 | 8693 | 11283 |
| Operating Profit | 929 | 1145 | 1257 | 1221 | 1429 | 1593 | 1685 | 1779 | 1954 | 2168 | 2346 | 2532 |
| Interest | 23 | 21 | 17 | 16 | 40 | 50 | 34 | 39 | 56 | 73 | 53 | 53 |
| Depreciation | 84 | 95 | 90 | 88 | 131 | 140 | 139 | 139 | 155 | 158 | 177 | 202 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | -29 | 13 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 822 | 1029 | 1149 | 1117 | 1257 | 1374 | 1523 | 1601 | 1743 | 1937 | 2116 | 2277 |
| Provision for Tax | 237 | 305 | 338 | 290 | 126 | 331 | 324 | 346 | 421 | 435 | 458 | 464 |
| Profit After Tax | 585 | 723 | 811 | 827 | 1131 | 1043 | 1199 | 1255 | 1322 | 1502 | 1658 | 1813 |
| Adjustments | -11 | -12 | -12 | -13 | -17 | -22 | -27 | -30 | -20 | -21 | -29 | -51 |
| Profit After Adjustments | 573 | 711 | 799 | 814 | 1114 | 1021 | 1172 | 1225 | 1302 | 1481 | 1629 | 1762 |
| Adjusted Earnings Per Share | 4.4 | 5.5 | 6.2 | 6.3 | 8.6 | 7.9 | 9.1 | 9.5 | 10.1 | 11.5 | 12.6 | 13.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 12% | 4% | 8% | 7% |
| Operating Profit CAGR | 8% | 10% | 8% | 10% |
| PAT CAGR | 10% | 10% | 10% | 11% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 15% | 14% | 11% | 13% |
| ROE Average | 43% | 40% | 40% | 38% |
| ROCE Average | 51% | 48% | 47% | 45% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 1825 | 2017 | 2326 | 2543 | 2976 | 3023 | 3240 | 3348 | 3799 | 3833 | 3974 |
| Minority's Interest | 14 | 14 | 13 | 12 | 12 | 13 | 18 | 57 | 157 | 337 | 291 |
| Borrowings | 169 | 0 | 0 | 20 | 14 | 10 | 8 | 0 | 2 | 0 | 0 |
| Other Non-Current Liabilities | 17 | -29 | 35 | 39 | -18 | 12 | 45 | 41 | 413 | 740 | 1554 |
| Total Current Liabilities | 1102 | 1565 | 1249 | 1458 | 1724 | 1753 | 2013 | 2153 | 2429 | 2444 | 2462 |
| Total Liabilities | 3125 | 3568 | 3623 | 4072 | 4708 | 4811 | 5324 | 5599 | 6800 | 7354 | 8281 |
| Fixed Assets | 1076 | 1050 | 1055 | 1080 | 1283 | 1379 | 1595 | 1738 | 2230 | 2709 | 2743 |
| Other Non-Current Assets | 221 | 159 | 179 | 198 | 225 | 283 | 393 | 356 | 750 | 642 | 455 |
| Total Current Assets | 1828 | 2346 | 2377 | 2794 | 3188 | 3141 | 3322 | 3505 | 3813 | 3998 | 5083 |
| Total Assets | 3125 | 3568 | 3623 | 4072 | 4708 | 4811 | 5324 | 5599 | 6800 | 7354 | 8281 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 224 | 79 | 93 | 43 | 51 | 48 | 93 | 109 | 276 | 207 | 228 |
| Cash Flow from Operating Activities | 665 | 818 | 649 | 516 | 1062 | 1214 | 2007 | 1016 | 1419 | 1387 | 1363 |
| Cash Flow from Investing Activities | -179 | -197 | -92 | 55 | -334 | -39 | -938 | 425 | -865 | 176 | -621 |
| Cash Flow from Financing Activities | -625 | -601 | -574 | -567 | -698 | -1147 | -1058 | -1290 | -560 | -1542 | -649 |
| Net Cash Inflow / Outflow | -140 | 20 | -17 | 4 | 30 | 28 | 11 | 151 | -6 | 21 | 93 |
| Closing Cash & Cash Equivalent | 77 | 93 | 43 | 51 | 48 | 93 | 109 | 276 | 207 | 228 | 321 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 4.45 | 5.51 | 6.19 | 6.31 | 8.64 | 7.91 | 9.09 | 9.5 | 10.09 | 11.48 | 12.63 |
| CEPS(Rs) | 5.19 | 6.34 | 6.98 | 7.09 | 9.78 | 9.17 | 10.37 | 10.81 | 11.45 | 12.87 | 14.22 |
| DPS(Rs) | 2.5 | 6.75 | 3.5 | 4.25 | 4.75 | 6.75 | 7.5 | 9.25 | 4.5 | 9.5 | 10.5 |
| Book NAV/Share(Rs) | 14.12 | 15.59 | 17.96 | 19.63 | 22.92 | 23.24 | 24.89 | 25.74 | 29.12 | 29.17 | 30.11 |
| Core EBITDA Margin(%) | 15.15 | 17.45 | 19.53 | 16.54 | 16.7 | 18.2 | 17.95 | 15.91 | 16.42 | 17.83 | 17.04 |
| EBIT Margin(%) | 14.71 | 17.43 | 19.63 | 16.49 | 16.33 | 17.67 | 17.6 | 15.55 | 16.32 | 17.99 | 17.29 |
| Pre Tax Margin(%) | 14.31 | 17.08 | 19.35 | 16.26 | 15.83 | 17.05 | 17.21 | 15.18 | 15.81 | 17.33 | 16.87 |
| PAT Margin (%) | 10.19 | 12.01 | 13.66 | 12.04 | 14.24 | 12.95 | 13.55 | 11.9 | 11.99 | 13.44 | 13.22 |
| Cash Profit Margin (%) | 11.66 | 13.58 | 15.18 | 13.32 | 15.89 | 14.68 | 15.12 | 13.21 | 13.4 | 14.85 | 14.63 |
| ROA(%) | 19.19 | 21.62 | 22.56 | 21.49 | 25.76 | 21.91 | 23.66 | 22.98 | 21.32 | 21.22 | 21.21 |
| ROE(%) | 36.76 | 37.75 | 37.47 | 34.1 | 41.21 | 35.03 | 38.62 | 38.43 | 37.36 | 39.95 | 43.36 |
| ROCE(%) | 39.35 | 45.64 | 47.43 | 41.81 | 41.95 | 42.58 | 44.79 | 45.03 | 45.16 | 47.35 | 50.62 |
| Receivable days | 12.71 | 12.99 | 15.34 | 15.59 | 19.7 | 23.92 | 19.12 | 17.99 | 27.6 | 34.03 | 34.04 |
| Inventory Days | 56.93 | 58.17 | 66.99 | 73.44 | 67.15 | 63.22 | 51.68 | 43.91 | 43.66 | 41.82 | 37.4 |
| Payable days | 74.53 | 86.66 | 105.01 | 95.3 | 91.98 | 107.61 | 100.01 | 92.75 | 107.65 | 131.67 | 110.99 |
| PER(x) | 43.53 | 43.97 | 47.57 | 51.68 | 39.98 | 34.73 | 45.29 | 53.04 | 47.53 | 43.28 | 51.59 |
| Price/Book(x) | 13.71 | 15.56 | 16.39 | 16.61 | 15.06 | 11.83 | 16.53 | 19.56 | 16.48 | 17.03 | 21.64 |
| Dividend Yield(%) | 0.65 | 2.78 | 1.19 | 1.3 | 1.38 | 2.46 | 1.82 | 1.84 | 0.94 | 1.91 | 1.61 |
| EV/Net Sales(x) | 4.39 | 5.2 | 6.42 | 6.67 | 6.05 | 4.86 | 6.52 | 6.81 | 6.31 | 6.58 | 7.72 |
| EV/Core EBITDA(x) | 27.11 | 27.33 | 30.23 | 34.54 | 31.03 | 22.29 | 31.15 | 36.39 | 31.53 | 29.31 | 35.65 |
| Net Sales Growth(%) | 22.33 | 4.96 | -1.65 | 6.83 | 16.01 | -0.26 | 10.02 | 18.19 | 2.65 | -1.14 | 12.2 |
| EBIT Growth(%) | 15.85 | 24.33 | 10.97 | -2.77 | 14.47 | 9.79 | 9.34 | 5.33 | 9.7 | 11.73 | 7.91 |
| PAT Growth(%) | 16.02 | 23.67 | 12.12 | 1.98 | 36.76 | -7.78 | 14.96 | 4.67 | 5.34 | 13.62 | 10.39 |
| EPS Growth(%) | 18.13 | 24.05 | 12.22 | 1.97 | 36.86 | -8.35 | 14.79 | 4.52 | 6.29 | 13.75 | 9.99 |
| Debt/Equity(x) | 0.23 | 0.16 | 0.1 | 0.12 | 0.12 | 0.11 | 0.11 | 0.1 | 0.13 | 0.1 | 0.1 |
| Current Ratio(x) | 1.66 | 1.5 | 1.9 | 1.92 | 1.85 | 1.79 | 1.65 | 1.63 | 1.57 | 1.64 | 2.06 |
| Quick Ratio(x) | 0.76 | 0.91 | 0.91 | 0.89 | 1.04 | 1.02 | 1.09 | 0.97 | 1.07 | 1.09 | 1.56 |
| Interest Cover(x) | 36.8 | 49.07 | 70.28 | 70.81 | 32.43 | 28.48 | 45.79 | 42.05 | 32.13 | 27.53 | 40.92 |
| Total Debt/Mcap(x) | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 59.39 | 59.35 | 59.28 | 59.2 | 59.11 | 59.05 | 59.03 | 58.94 | 58.93 | 58.93 |
| FII | 25.69 | 25.54 | 24.61 | 24.87 | 23.36 | 22.08 | 23.62 | 24.21 | 24.01 | 24.08 |
| DII | 9.73 | 9.88 | 11.2 | 11.13 | 12.78 | 14.2 | 12.7 | 11.98 | 12.33 | 12.29 |
| Public | 5.19 | 5.22 | 4.9 | 4.8 | 4.76 | 4.66 | 4.65 | 4.87 | 4.72 | 4.7 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 76.84 | 76.8 | 76.75 | 76.65 | 76.56 | 76.5 | 76.5 | 76.49 | 76.49 | 76.49 |
| FII | 33.24 | 33.06 | 31.86 | 32.2 | 30.25 | 28.61 | 30.62 | 31.42 | 31.17 | 31.26 |
| DII | 12.59 | 12.79 | 14.51 | 14.41 | 16.55 | 18.4 | 16.45 | 15.55 | 16.01 | 15.96 |
| Public | 6.72 | 6.76 | 6.34 | 6.21 | 6.16 | 6.04 | 6.03 | 6.33 | 6.13 | 6.1 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 129.39 | 129.41 | 129.46 | 129.47 | 129.52 | 129.55 | 129.6 | 129.79 | 129.81 | 129.81 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +12% | +4% | +8% | +7% |
| Operating Profit CAGR | +8% | +10% | +8% | +10% |
| PAT CAGR | +10% | +10% | +10% | +11% |
| Share Price CAGR | +15% | +14% | +11% | +13% |
| ROE Average | +43% | +40% | +40% | +38% |
| ROCE Average | +51% | +48% | +47% | +45% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 59.39 | 59.35 | 59.28 | 59.2 | 59.11 | 59.05 | 59.03 | 58.94 | 58.93 | 58.93 |
| FII | 25.69 | 25.54 | 24.61 | 24.87 | 23.36 | 22.08 | 23.62 | 24.21 | 24.01 | 24.08 |
| DII | 9.73 | 9.88 | 11.2 | 11.13 | 12.78 | 14.2 | 12.7 | 11.98 | 12.33 | 12.29 |
| Public | 40.61 | 40.65 | 40.72 | 40.8 | 40.89 | 40.95 | 40.97 | 41.06 | 41.07 | 41.07 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 76.84 | 76.8 | 76.75 | 76.65 | 76.56 | 76.5 | 76.5 | 76.49 | 76.49 | 76.49 |
| FII | 33.24 | 33.06 | 31.86 | 32.2 | 30.25 | 28.61 | 30.62 | 31.42 | 31.17 | 31.26 |
| DII | 12.59 | 12.79 | 14.51 | 14.41 | 16.55 | 18.4 | 16.45 | 15.55 | 16.01 | 15.96 |
| Public | 52.54 | 52.61 | 52.71 | 52.82 | 52.96 | 53.05 | 53.1 | 53.3 | 53.31 | 53.32 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 129.39 | 129.41 | 129.46 | 129.47 | 129.52 | 129.55 | 129.6 | 129.79 | 129.81 | 129.81 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.